Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoterMichael Lim, Antonio Omuro, Michael Weller et al.|Neuro-Oncology|2022Cited by 508
A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)Solmaz Sahebjam, Sebastién J. Hotte|British Journal of Cancer|2013Cited by 76
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patientsEudocia Q. Lee, Patrick Y. Wen, Matthias Holdhoff et al.|Neuro-Oncology|2020Cited by 40
Progression Pattern and Adverse Events with Bevacizumab in GlioblastomaAline Mamo, Petr Kavan, Ayesha Baig et al.|Current Oncology|2016Cited by 12
Bevacizumab Use for Recurrent High-Grade Glioma at McGill University HospitalSolmaz Sahebjam, Petr Kavan, Evgenia Garoufalis et al.|Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques|2013Cited by 5